v3.25.2
FAIR VALUE MEASUREMENTS - Reconciliation of our assets and liabilities measured at fair value using Level 3 inputs (Details)
3 Months Ended
Mar. 31, 2025
USD ($)
Derivative liabilities  
Fair value, liabilities measured on recurring basis  
Balance, December 31, 2024 $ (4,229,478)
Settlement through issuance of Company's common stock 1,712,005
Day one gain on issuance (33,814)
Ending balance, March 31, 2025 (2,551,287)
3(a)(10) Settlement Agreement  
Fair value, liabilities measured on recurring basis  
Issuances (11,623,946)
Settlement through issuance of Company's common stock 3,077,252
Day one gain on issuance 605,748
Ending balance, March 31, 2025 (7,940,946)
Contingent consideration  
Fair value, liabilities measured on recurring basis  
Balance, December 31, 2024 (434,174)
Ending balance, March 31, 2025 (434,174)
Convertible debt  
Fair value, liabilities measured on recurring basis  
Balance, December 31, 2024 (8,542,323)
Issuances (2,530,000)
Settlement through issuance of Company's common stock 3,630,000
Day one gain on issuance (319,695)
Ending balance, March 31, 2025 (7,762,018)
Forward purchase agreement  
Fair value, assets measured on recurring basis  
Balance, December 31, 2024 1,471,000
Change in fair value (971,000)
Ending balance, March 31, 2025 $ 500,000